Which is more profitable, Medtronic or Novo Nordisk?

Novo Nordisk keeps more of every sale as profit.

Which grows faster, Medtronic or Novo Nordisk?

Novo Nordisk grew its sales faster in recent years.

Which is cheaper, Medtronic or Novo Nordisk?

Novo Nordisk costs less for each unit of yearly profit (lower P/E).

Which has less debt, Medtronic or Novo Nordisk?

Novo Nordisk would need fewer years of earnings to pay off its debt.

MedtronicMDTvs

Novo NordiskNVO

Medtronic vs Novo Nordisk stock

Side by side in plain words: who keeps more of its sales, grows faster, costs less and owes less.

In one sentence

Novo Nordisk is more profitable, grows faster, is cheaper for its profits and has less debt.

Side by side

	Medtronic	Novo Nordisk
	$132 billion	$184 billion
	13.2%	33.1%
	+3.8%	+20.4%
	27.4×	12.2×
	2.7 years	0.7 years
	7.2%	33.6%
	3.5%	4.2%

Open Medtronic Open Novo Nordisk

How we compare

Four contests with the same rules as each stock page: profit kept from sales (higher wins), yearly sales growth across the last reports, up to five years (higher wins), price per unit of yearly profit (lower P/E wins; a company without profit loses) and debt in years of earnings (lower wins). A winner is only named when both companies have the number.

More comparisons: Medtronic vs Regeneron Pharmaceuticals · Medtronic vs Roche · Medtronic vs Thermo Fisher Scientific · Medtronic vs UnitedHealth · Novo Nordisk vs Roche · Novo Nordisk vs UnitedHealth · Novo Nordisk vs AbbVie · Novo Nordisk vs Bristol-Myers Squibb